Showing Results for
- Academic Journals (21)
Search Results
- 21
Academic Journals
- 21
- Search Terms:ISSN: 15491277AndISSN: 15491676AndVolume Number: 8AndIssue Number: 1AndStart Page: e1000402AndDate: 2011 Revise Search
- 1From: PLoS Medicine. (Vol. 8, Issue 1) Peer-ReviewedHealth systems research and development is needed to support the global malaria eradication agenda. In this paper, we (the malERA Consultative Group on Health Systems and Operational Research) focus on the health...
- 2From: PLoS Medicine. (Vol. 8, Issue 1) Peer-ReviewedMonitoring, evaluation, and surveillance measure how well public health programs operate over time and achieve their goals. As countries approach malaria elimination, these activities will need to shift from measuring...
- 3From: PLoS Medicine. (Vol. 8, Issue 1) Peer-ReviewedIt seems astonishing that in the 21st century decisions on health care can still be made without a solid grounding in research evidence. This is true even in clinical research, whether for simple or complex...
- 4From: PLoS Medicine. (Vol. 8, Issue 1) Peer-ReviewedBackground: Maternal and perinatal mortality could be reduced if all women delivered in settings where skilled attendants could provide emergency obstetric care (EmOC) if complications arise. Research on determinants of...
- 5From: PLoS Medicine. (Vol. 8, Issue 1) Peer-ReviewedVaccines could be a crucial component of efforts to eradicate malaria. Current attempts to develop malaria vaccines are primarily focused on Plasmodium falciparum and are directed towards reducing morbidity and...
- 6From: PLoS Medicine. (Vol. 8, Issue 1) Peer-ReviewedMalaria modeling can inform policy and guide research for malaria elimination and eradication from local implementation to global policy. A research and development agenda for malaria modeling is proposed, to support...
- 7From: PLoS Medicine. (Vol. 8, Issue 1) Peer-ReviewedBackground: There is considerable international interest in exploiting the potential of digital solutions to enhance the quality and safety of health care. Implementations of transformative eHealth technologies are...
- 8From: PLoS Medicine. (Vol. 8, Issue 1) Peer-ReviewedBy examining the role research has played in eradication or regional elimination initiatives for three viral diseases--smallpox, poliomyelitis, and measles--we derive nine cross-cutting lessons applicable to malaria...
- 9From: PLoS Medicine. (Vol. 8, Issue 1) Peer-ReviewedBackground: The World Health Organization recommends the screening of all people living with HIV for tuberculosis (TB) disease, followed by TB treatment, or isoniazid preventive therapy (IPT) when TB is excluded....
- 10From: PLoS Medicine. (Vol. 8, Issue 1) Peer-ReviewedIntroduction It is estimated that 3.2 million stillbirths occur each year globally, 1 million of which happen during birth [1]. In addition, complications from preterm birth (before 37 completed weeks of gestation)...
- 11From: PLoS Medicine. (Vol. 8, Issue 1) Peer-ReviewedWhat Are Core Outcome Sets and Why Are They Useful? Good clinical trial design requires researchers to specify in advance, in the protocol, those outcomes to be measured. If research has not been conducted to...
- 12From: PLoS Medicine. (Vol. 8, Issue 1) Peer-ReviewedEncouraged by the early success of using dichloro-diphenyl-trichloroethane (DDT) against malaria, the World Health Organization (WHO) embarked on the Global Malaria Eradication Program (GMEP) in 1955. Fourteen years...
- 13From: PLoS Medicine. (Vol. 8, Issue 1) Peer-ReviewedToday's malaria control efforts are limited by our incomplete understanding of the biology of Plasmodium and of the complex relationships between human populations and the multiple species of mosquito and parasite....
- 14From: PLoS Medicine. (Vol. 8, Issue 1) Peer-ReviewedMany of malaria's signs and symptoms are indistinguishable from those of other febrile diseases. Detection of the presence of Plasmodium parasites is essential, therefore, to guide case management. Improved diagnostic...
- 15From: PLoS Medicine. (Vol. 8, Issue 1) Peer-ReviewedDifferent challenges are presented by the variety of malaria transmission environments present in the world today. In each setting, improved control for reduction of morbidity is a necessary first step towards the...
- 16From: PLoS Medicine. (Vol. 8, Issue 1) Peer-ReviewedUNAIDS and the World Health Organization estimate that in 2009, about 33.3 million people in the world were infected with HIV, of which approximately 5.2 million were on antiretroviral therapy (ART). This proportion...
- 17From: PLoS Medicine. (Vol. 8, Issue 1) Peer-ReviewedThe interruption of malaria transmission worldwide is one of the greatest challenges for international health and development communities. The current expert view suggests that, by aggressively scaling up control with...
- 18From: PLoS Medicine. (Vol. 8, Issue 1) Peer-ReviewedDiscipline-specific Malaria Eradication Research Agenda (malERA) Consultative Groups have recognized several cross-cutting issues that must be addressed to prevent repetition of some of the mistakes of past malaria...
- 19From: PLoS Medicine. (Vol. 8, Issue 1) Peer-ReviewedBackground: The World Health Organization estimates that in sub-Saharan Africa about 4 million HIV-infected patients had started antiretroviral therapy (ART) by the end of 2008. Loss of patients to follow-up and care is...
- 20From: PLoS Medicine. (Vol. 8, Issue 1) Peer-ReviewedAntimalarial drugs will be essential tools at all stages of malaria elimination along the path towards eradication, including the early control or "attack" phase to drive down transmission and the later stages of...